Insider Trading activities at Sangamo Therapeutics, Inc (SGMO)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sangamo Therapeutics, Inc (SGMO) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sangamo Therapeutics, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1001233.

Total stock buying since 2014: $2,265,625.
Total stock sales since 2014: $84,054,463.
Total stock option exercises since 2014: $7,870,680.

1 2

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Sangamo Therapeutics, Inc* (*SGMO*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2023	0	$0	6,000,000	$3,000,000	0	$0
2022	21,784	$79,011	500,000	$2,657,300	0	$0
2021	0	$0	285,215	$2,526,092	11,981	$132,030
2020	28,000	$163,535	65,795	$534,643	74,907	$330,900
2019	0	$0	30,000	$327,379	41,137	$129,750
2018	11,408	$145,531	203,059	$3,698,265	208,908	$1,189,896
2017	0	$0	130,546	$1,840,392	104,395	$730,815
2015	0	$0	504,501	$7,183,477	494,000	$2,890,412
2014	156,251	$1,877,548	4,578,354	$62,286,915	524,086	$2,466,877

Table 2. Monthly summary of insider trading at *Sangamo Therapeutics, Inc* (*SGMO*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2023-09	0	$0	6,000,000	$3,000,000	0	$0
2022-08	0	$0	500,000	$2,657,300	0	$0
2022-06	21,784	$79,011	0	$0	0	$0
2021-12	0	$0	238,807	$2,047,186	0	$0
2021-11	0	$0	28,884	$248,431	0	$0
2021-03	0	$0	17,524	$230,475	11,981	$132,030
2020-12	0	$0	15,795	$234,388	10,000	$59,900
2020-06	0	$0	0	$0	14,907	$0
2020-03	28,000	$163,535	50,000	$300,255	50,000	$271,000
2019-08	0	$0	0	$0	11,137	$0
2019-05	0	$0	5,000	$50,000	5,000	$22,750
2019-04	0	$0	5,000	$60,550	5,000	$22,750
2019-03	0	$0	10,000	$100,000	10,000	$45,500
2019-01	0	$0	10,000	$116,829	10,000	$38,750
2018-12	0	$0	10,000	$114,635	10,000	$38,750
2018-11	2,000	$18,002	10,000	$118,650	10,000	$38,750
2018-10	0	$0	10,000	$142,625	10,000	$38,750
2018-09	9,408	$127,529	10,000	$144,130	10,000	$38,750
2018-08	0	$0	10,000	$144,200	10,000	$38,750
2018-07	0	$0	10,000	$152,835	10,000	$38,750
2018-06	0	$0	10,000	$161,715	10,000	$38,750
2018-05	0	$0	10,000	$158,735	10,000	$38,750
2018-04	0	$0	27,656	$525,690	30,441	$246,007
2018-03	0	$0	34,433	$817,088	40,000	$271,175

Table 3. Detailed insider trading at *Sangamo Therapeutics, Inc* (*SGMO*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2023-09-26	Biogen Ma Inc. (10% Owner)	Sale	6,000,000	.50	3,000,000
2022-08-30	Biogen Ma Inc. (10% Owner)	Sale	100,000	5.26	526,500
2022-08-29	Biogen Ma Inc. (10% Owner)	Sale	400,000	5.33	2,130,800
2022-06-03	Markels John (Director)	Buy	6,784	3.69	25,026
2022-06-01	Parker H Stewart (Director)	Buy	10,000	3.60	35,990
2021-12-28	Biogen Ma Inc.	Sale	2,764	8.51	23,521
2021-12-27	Biogen Ma Inc.	Sale	600	8.56	5,136
2021-12-23	Biogen Ma Inc.	Sale	81,187	8.55	694,554
2021-12-09	Biogen Ma Inc.	Sale	23,660	8.56	202,553
2021-12-08	Biogen Ma Inc.	Sale	75,814	8.64	654,805
2021-12-07	Biogen Ma Inc.	Sale	52,178	8.52	444,452
2021-12-02	Biogen Ma Inc.	Sale	1,874	8.51	15,942
2021-12-01	Biogen Ma Inc.	Sale	730	8.53	6,223
2021-11-26	Biogen Ma Inc.	Sale	28,884	8.60	248,431
2021-03-23	Loeb Gary (EVP, General Counsel & Sec.)	Sale	17,524	13.15	230,475
2021-03-23	Loeb Gary (EVP, General Counsel & Sec.)	Option Ex	11,981	11.02	132,030
2020-12-31	Ramelmeier Rolf Andrew (EVP, Technical Operations)	Sale	2,464	16.74	41,247
2020-12-24	Ramelmeier Rolf Andrew (EVP, Technical Operations)	Sale	3,331	18.13	60,391
2020-12-17	Ramasastry Saira (Director)	Sale	10,000	13.28	132,750
2020-12-17	Ramasastry Saira (Director)	Option Ex	10,000	5.99	59,900
2020-06-04	Boissel Stephane (EVP, Corp. Strategy)	Option Ex	14,907	.00	0
2020-03-19	Dilly Stephen George (Director)	Sale	35,000	6.00	210,000
2020-03-19	Dilly Stephen George (Director)	Option Ex	35,000	5.42	189,700
2020-03-18	Parker H Stewart (Director)	Buy	3,000	5.20	15,585
2020-03-17	Zakrzewski Joseph S (Director)	Buy	5,000	4.99	24,950
2020-03-16	Dilly Stephen George (Director)	Sale	15,000	6.02	90,255
2020-03-16	Dilly Stephen George (Director)	Option Ex	15,000	5.42	81,300
2020-03-13	Zakrzewski Joseph S (Director)	Buy	5,000	5.67	28,350
2020-03-12	Zakrzewski Joseph S (Director)	Buy	15,000	6.31	94,650
2019-08-12	Boissel Stephane (EVP, Corp. Strat. & Int. CFO)	Option Ex	11,137	.00	0
2019-05-15	Yi Kathy (EVP & Chief Financial Officer)	Sale	5,000	10.00	50,000
2019-05-15	Yi Kathy (EVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2019-04-15	Yi Kathy (EVP & Chief Financial Officer)	Sale	5,000	12.11	60,550
2019-04-15	Yi Kathy (EVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2019-03-15	Yi Kathy (EVP & Chief Financial Officer)	Sale	5,000	10.00	50,000
2019-03-15	Yi Kathy (EVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2019-03-01	Yi Kathy (EVP & Chief Financial Officer)	Sale	5,000	10.00	50,000
2019-03-01	Yi Kathy (EVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2019-01-15	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	11.04	55,199
2019-01-15	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2019-01-07	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	12.33	61,630
2019-01-07	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-12-17	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	11.44	57,200
2018-12-17	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-12-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	11.49	57,435
2018-12-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-11-15	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	10.00	50,000
2018-11-15	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-11-14	Parker H Stewart (Director)	Buy	2,000	9.00	18,002
2018-11-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	13.73	68,650
2018-11-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-10-15	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	13.97	69,850
2018-10-15	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-10-08	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	14.55	72,775
2018-10-08	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-09-17	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	14.66	73,285
2018-09-17	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-09-07	Jeffs Roger (Director)	Buy	7,408	13.56	100,489
2018-09-07	Parker H Stewart (Director)	Buy	2,000	13.52	27,040
2018-09-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	14.17	70,845
2018-09-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-08-16	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	15.39	76,950
2018-08-16	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-08-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	13.45	67,250
2018-08-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-07-16	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	14.77	73,860
2018-07-16	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-07-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	15.79	78,975
2018-07-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-06-15	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	15.67	78,365
2018-06-15	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-06-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	16.67	83,350
2018-06-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-05-15	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	15.38	76,920
2018-05-15	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-05-07	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	16.36	81,815
2018-05-07	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-04-16	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	19.83	99,145
2018-04-16	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-04-13	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	8,163	20.00	163,260
2018-04-13	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	8,163	14.07	114,853
2018-04-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	17.41	87,065
2018-04-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-04-02	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	2,278	18.30	41,682
2018-04-02	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	2,278	6.46	14,704
2018-04-02	Mento Steven J (Director)	Sale	7,215	18.65	134,538
2018-04-02	Mento Steven J (Director)	Option Ex	10,000	7.77	77,700
2018-03-15	Yi Kathy (SVP & Chief Financial Officer)	Sale	5,000	25.56	127,810
2018-03-15	Yi Kathy (SVP & Chief Financial Officer)	Option Ex	5,000	4.55	22,750
2018-03-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	24.78	123,880
2018-03-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-03-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	15,000	23.06	345,855
2018-03-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	15,000	9.78	146,625
2018-03-01	Mento Steven J (Director)	Sale	9,433	23.27	219,543
2018-03-01	Mento Steven J (Director)	Option Ex	15,000	5.72	85,800
2018-02-26	Ramasastry Saira (Director)	Sale	9,450	24.88	235,078
2018-02-26	Ramasastry Saira (Director)	Option Ex	9,450	5.03	47,533
2018-02-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	18.49	92,434
2018-02-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-02-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	15,000	20.59	308,850
2018-02-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	15,000	3.50	52,500
2018-02-01	Mento Steven J (Director)	Sale	11,520	20.59	237,162
2018-02-01	Mento Steven J (Director)	Option Ex	15,000	8.29	124,349
2018-01-08	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	17.11	85,545
2018-01-08	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2018-01-03	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	8,026	18.05	144,869
2018-01-03	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	8,026	12.12	97,275
2018-01-02	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	6,974	16.35	114,024
2018-01-02	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	991	9.14	9,057
2017-12-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Sale	5,000	16.24	81,199
2017-12-06	Conner Edward R. (Sr. VP & Chief Medical Officer)	Option Ex	5,000	3.20	16,000
2017-12-04	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	11,803	18.00	212,454
2017-12-04	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	11,803	12.12	143,052
2017-12-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	3,197	16.70	53,389
2017-12-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	1,197	9.14	10,940
2017-11-30	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	13,433	16.00	214,928
2017-11-30	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	13,433	9.41	126,404
2017-11-17	Ramasastry Saira (Director)	Sale	5,000	14.67	73,340
2017-11-17	Ramasastry Saira (Director)	Option Ex	5,000	5.03	25,150
2017-10-02	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	15,000	15.33	229,995
2017-10-02	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	15,000	7.90	118,455
2017-09-20	Ringo William R (Director)	Sale	31,000	14.37	445,594
2017-09-20	Ringo William R (Director)	Option Ex	31,000	6.05	187,550
2017-09-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	15,000	15.00	225,000
2017-09-01	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	10,316	5.41	55,809
2017-08-14	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	5,000	11.00	55,000
2017-08-14	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	5,000	5.12	25,600
2017-08-11	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	6,474	10.00	64,740
2017-08-11	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	6,474	3.27	21,169
2017-07-14	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Sale	15,000	10.00	150,000
2017-07-14	Herberts Curt A. Iii (Sr.VP & Chief Business Officer)	Option Ex	172	3.99	686
2017-06-01	Herberts Curt A. Iii (Senior VP & CBO)	Sale	2,000	6.80	13,600
2017-05-12	Herberts Curt A. Iii (Senior VP & CBO)	Sale	2,000	8.50	17,000
2017-05-11	Herberts Curt A. Iii (Senior VP & CBO)	Sale	639	6.50	4,153
2015-07-15	Lanphier Edward O Ii (President & CEO)	Sale	25,000	10.43	260,774
2015-07-15	Lanphier Edward O Ii (President & CEO)	Option Ex	25,000	6.82	170,500
2015-07-13	Wolff Henry Ward (Exec VP & CFO)	Sale	5,898	10.00	58,980
2015-07-13	Wolff Henry Ward (Exec VP & CFO)	Option Ex	3,898	3.45	13,448
2015-07-10	Wolff Henry Ward (Exec VP & CFO)	Sale	6,102	10.00	61,020
2015-07-10	Wolff Henry Ward (Exec VP & CFO)	Option Ex	6,102	3.45	21,051
2015-06-15	Lanphier Edward O Ii (President & CEO)	Sale	25,000	11.08	277,075
2015-06-15	Lanphier Edward O Ii (President & CEO)	Option Ex	25,000	6.82	170,500
2015-06-10	Wolff Henry Ward (Exec VP & CFO)	Sale	12,000	12.21	146,556
2015-06-10	Wolff Henry Ward (Exec VP & CFO)	Option Ex	10,000	3.45	34,500
2015-06-05	Ando Dale G (VP, Therapeutic Dev. & CMO)	Sale	15,000	12.29	184,395
2015-06-05	Ando Dale G (VP, Therapeutic Dev. & CMO)	Option Ex	15,000	3.45	51,750
2015-06-03	Ringo William R	Sale	2,200	12.44	27,363
2015-06-03	Ringo William R	Option Ex	2,200	6.05	13,310
2015-06-01	Gregory Philip D (SVP of Research & CSO)	Sale	15,000	12.39	185,820
2015-06-01	Gregory Philip D (SVP of Research & CSO)	Option Ex	15,000	4.83	72,495

1 2

Insider trading activities including stock purchases, stock sales, and option exercises of SGMO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sangamo Therapeutics, Inc (symbol SGMO, CIK number 1001233) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month